Curatis Holding AG (XSWX:CURN) ROE % Adjusted to Book Value : -54.33% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG ROE % Adjusted to Book Value?

Curatis Holding AG's ROE % for the quarter that ended in Jun. 2024 was -37.49%. Curatis Holding AG's PB Ratio for the quarter that ended in Jun. 2024 was 0.69. Curatis Holding AG's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -54.33%.

Curatis Holding AG ROE % Adjusted to Book Value Historical Data

The historical data trend for Curatis Holding AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG ROE % Adjusted to Book Value Chart

Curatis Holding AG Annual Data

Trend

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-572.46

Curatis Holding AG Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-9.52	-159.01	-31.61	-	-54.33

Competitive Comparison of Curatis Holding AG's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curatis Holding AG's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's ROE % Adjusted to Book Value falls into.

Curatis Holding AG ROE % Adjusted to Book Value Calculation

Curatis Holding AG's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-1,533.30%	/	N/A
	=	N/A

Curatis Holding AG's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-37.49%	/	0.69
	=	-54.33%

Curatis Holding AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

CURNz:UK 0QNS:UK

Address

Weierweg 7, Liestal, CHE, CH-4410

Website

https://www.curatis.com

Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.